| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000261024.2 |
Tanespimycin |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027447634 |
Resistant |
| ENSG00000261024.2 |
Tanespimycin |
Brain lower grade glioma |
0.023940416 |
Resistant |
| ENSG00000261024.2 |
Tanespimycin |
Lung squamous cell carcinoma |
0.00415143 |
Resistant |
